Abstract

Remdesivir and Lopinavir/Ritonavir as Potential Drugs to Treat Coronavirus Disease 2019 (COVID-19)

Drugs that are efficacious against SARS-CoV-2 have yet to be established. Remdesivir and Lopinavir/ritonavir have garnered considerable attention for their potential to treat coronavirus disease 2019 (COVID-19).

Remdesivir not only in vivo but also in vitro testing shows the inhibition of human coronavirus replication, including SARS-CoV-2 as well as Lopinavir/ritonavir that shows promising antiviral drug against SARS-CoV-2.


Author(s):

Bzikha Reda*, Bouhmou Ayoub, Bzikha Ilham, Bouchnafati Sanaa



Abstract | Full-Text | PDF

Share this  Facebook  Twitter  LinkedIn  Google+
Recommended Conferences
Flyer image
Abstracted/Indexed in
  • Google Scholar
  • China National Knowledge Infrastructure (CNKI)
  • Secret Search Engine Labs